Percutaneous Tracheostomy With COVID-19

NCT04447638 — Completed, 24 participants, Çanakkale Onsekiz Mart University

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Percutaneous Tracheostomy With Aerosol Box in COVID-19 Positive Patients in Intensive Care Unit: a Clinical Trial

Registry	NCT04447638
Status	Completed
Study type	Observational
Enrollment	24 (Actual)
Sponsor	Çanakkale Onsekiz Mart University (Other)
Conditions	Tracheostomy
Interventions	Tracheostomy with aerosol box in COVID-19 positive patients (Procedure)
Dates	start 2020-03-20, primary completion 2020-06-01, completion 2020-06-01, first posted 2020-06-25, last updated 2020-09-24
Locations	1 site in Turkey (Türkiye)

-Summary

Coronavirus disease 2019 (COVID-19) has brought about a requirement of intensive care and mechanical ventilation for a significant portion of patients. Percutaneous tracheostomy is performed in order to reduce the complications that may develop due to prolonged endotracheal intubation.

Expand all sections · Collapse all

+Detailed description

Different methods are needed for situations in which the potential for producing aerosols is high, such as intubation and tracheostomy. One of these methods is the aerosol box.To share our experiences of percutaneous tracheostomy performed with aerosol box in COVID-19 patients. Patients who underwent percutaneous tracheostomy between March 2020 and June 2020 in the pandemic intensive care unit were evaluated retrospectively.The study is designed as a clinical trial study. This study was performed in faculty of medicine hospital's intensive care unit which is located in Canakkale province Turkey.

+Arms and interventions

Tracheostomy with aerosol box in COVID-19 positive patients (Procedure): Patients who underwent percutaneous tracheostomy with aerosol box in COVID-19 positive patients. The patients age, gender, hospitalization diagnosis, number of intubated days, anesthetic agents used during the procedure, neck ultrasonography data before and during the procedure, and complications were recorded.

+Outcome measures

Primary outcomes

Complications observed in the cases in which we applied percutaneous tracheostomy with aerosol box [During the procedure]: Complications

+Eligibility

Sex: All, ages: 18 Years to 90 Years

Inclusion Criteria:

* who underwent percutaneous tracheostomy with COVID-19(+)

Exclusion Criteria:

* Patients who do not give informed consent or do not want to participate in the study
* Coagulopathy, thrombocytopenia

+Locations (1)

Facility	City	Country	Status
Canakkale Onsekiz Mart University	Çanakkale	Turkey (Türkiye)